ArticleEuropean journal of breast health2025
Breast Imaging: Correlation Between Axillary Lymph Nodes Apparent Diffusion Coefficient and Pathological Lymphovascular Invasion in Patients With Invasive Breast Cancer.
Article in European journal of breast health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Survey of the Senologic International Society (SIS) on the Use of Preoperative Breast MRI in Early-Stage Breast Cancer: A Global Perspective on Current Practice.European journal of breast health · 2026Article
- Morphologic and Diffusion-weighted MRI Characteristics of Axillary Lymph Nodes for Predicting Metastasis in Breast Cancer Patients: A Quantitative Analysis.Current medical imaging · 2026Article
- Comment on the "Breast Imaging: Correlation Between Axillary Lymph Nodes Apparent Diffusion Coefficient and Pathological Lymphovascular Invasion in Patients With Invasive Breast Cancer".European journal of breast health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Together with local invasion, one of the important characteristics of cancer is its capacity to spread, resulting in metastases. Before cancer cells metastasize to a secondary site, they must first enter and spread through the blood and lymph vasculature, this is known as lymphovascular invasion (LVI). This LVI and, to a much lesser extent, perineural and neural invasion are one of the biologic prerequisites for systemic spread and metastases. To evaluate the correlation between pre-operative apparent diffusion coefficient (ADC) of the ipsilateral enlarged axillary lymph nodes (LNs) and presence of LVI on post-operative pathology, in patients with invasive breast cancer. Materials and Methods: This retrospective study was approved by the institutional review board. It included 100 female patients (mean age, 49 years; range, 30-68 years) with invasive breast cancer, who underwent preoperative magnetic resonance imaging (MRI) and breast surgery. On pre-operative MRI, the ADC was calculated for the ipsilateral enlarged axillary LN. Presence or absence of LVI was assessed on post-operative histopathology. Statistical analysis was performed to investigate any correlation between the ADC value of the axillary LNs and LVI in these patients. Results: The mean ADC value of the ipsilateral enlarged axillary LNs was significantly lower in LVI positive cases compared to LVI negative cases (0.735 × 10 Conclusion: In cases of invasive breast cancer, the ADC value of the ipsilateral enlarged axillary LNs assessed on pre-operative MRI, and Ki-67 status of the tumor were significantly correlated to the LVI status on histopathological assessment. This ADC value may be useful as a predictor of axillary LN involvement, metastasis, and prognosis in invasive breast cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.